Zobrazeno 1 - 10
of 179
pro vyhledávání: '"A, Falzea"'
Publikováno v:
Feminismo/s, Iss 43, Pp 177-212 (2024)
This research paper conducts a Critical Discourse Analysis of the Instagram campaign run by WeAreHERe, a peer-to-peer mentorship program designed for women high school students and first-year university students at Politecnico di Torino. The study sc
Externí odkaz:
https://doaj.org/article/516a2dea32494b40a836ea4fddcce7e4
Publikováno v:
Quaderni di Sociologia, Vol 89, Iss 66, Pp 109-131 (2022)
Elias extensively studied the socialization process through figurations. However, he never explored specifically gender socialization and gender relations. Integrating the eliasian perspective with the one of Connell about configurations of gender pr
Externí odkaz:
https://doaj.org/article/118547a04d3146ec9d06b641a9f74cab
Autor:
Antonella Fameli, Valerio Nardone, Mojtaba Shekarkar Azgomi, Giovanna Bianco, Claudia Gandolfo, Bianca Maria Oliva, Marika Monoriti, Rita Emilena Saladino, Antonella Falzea, Caterina Romeo, Natale Daniele Calandruccio, Domenico Azzarello, Rocco Giannicola, Luigi Pirtoli, Antonio Giordano, Pierfrancesco Tassone, Pierosandro Tagliaferri, Maria Grazia Cusi, Luciano Mutti, Cirino Botta, Pierpaolo Correale
Publikováno v:
Frontiers in Oncology, Vol 12 (2022)
Peripheral immune-checkpoint blockade with mAbs to programmed cell death receptor-1 (PD-1) (either nivolumab or pembrolizumab) or PD-Ligand-1 (PD-L1) (atezolizumab, durvalumab, or avelumab) alone or in combination with doublet chemotherapy represents
Externí odkaz:
https://doaj.org/article/7c83e17e42a94c91add14fbda6384ccb
Autor:
Valerio Nardone, Rocco Giannicola, Giovanna Bianco, Diana Giannarelli, Paolo Tini, Pierpaolo Pastina, Antonia Consuelo Falzea, Sebastiano Macheda, Michele Caraglia, Amalia Luce, Silvia Zappavigna, Luciano Mutti, Luigi Pirtoli, Antonio Giordano, Pierpaolo Correale
Publikováno v:
Frontiers in Oncology, Vol 11 (2021)
Peripheral-immune-checkpoint blockade (P-ICB) with mAbs to PD-1 (nivolumab and pembrolizumab) or PD-L1 (atezolizumab, durvalumab, avelumab) alone or combination with chemotherapy represents a novel active treatment for mNSCLC patients. However, this
Externí odkaz:
https://doaj.org/article/44c6f43b72ed4333ad3dfa420b56c3ce
Autor:
Massimo Caracciolo, Pierpaolo Correale, Carmelo Mangano, Giuseppe Foti, Carmela Falcone, Sebastiano Macheda, Maria Cuzzola, Marco Conte, Antonella Consuelo Falzea, Eleonora Iuliano, Antonella Morabito, Michele Caraglia, Nicola Polimeni, Anna Ferrarelli, Demetrio Labate, Marco Tescione, Laura Di Renzo, Gaetano Chiricolo, Lorenzo Romano, Antonino De Lorenzo
Publikováno v:
Frontiers in Immunology, Vol 12 (2021)
Lack of specific antiviral treatment for COVID-19 has resulted in long hospitalizations and high mortality rate. By harnessing the regulatory effects of adenosine on inflammatory mediators, we have instituted a new therapeutic treatment with inhaled
Externí odkaz:
https://doaj.org/article/05c5ea14673c410a88457a775b784ddb
Autor:
Rita Emilena Saladino, Rocco Giannicola, Rita Agostino, Nicoletta Staropoli, Alessandra Strangio, Teresa Del Giudice, Maria Altomonte, Paolo Tini, Antonia Consuelo Falzea, Natale Imbesi, Valentina Arcati, Giuseppa Romeo, Daniele Caracciolo, Amalia Luce, Michele Caraglia, Antonio Giordano, Alois Necas, Evzen Amler, Vito Barbieri, Pierfrancesco Tassone
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 8, Iss 1 (2020)
Background Nivolumab is a human monoclonal antibody against programmed cell death receptor-1 (PD-1) able to rescue quiescent tumor infiltrating cytotoxic T lymphocytes (CTLs) restoring their ability to kill target cells expressing specific tumor anti
Externí odkaz:
https://doaj.org/article/903b06629eeb4b71bbf87b7168ef20f5
Autor:
Pierpaolo Correale, Massimo Caracciolo, Federico Bilotta, Marco Conte, Maria Cuzzola, Carmela Falcone, Carmelo Mangano, Antonella Consuelo Falzea, Eleonora Iuliano, Antonella Morabito, Giuseppe Foti, Antonio Armentano, Michele Caraglia, Antonino De Lorenzo, Michail Sitkovsky, Sebastiano Macheda
Publikováno v:
PLoS ONE, Vol 15, Iss 10, p e0239692 (2020)
BackgroundSARS-Cov2 infection may trigger lung inflammation and acute-respiratory-distress-syndrome (ARDS) that requires active ventilation and may have fatal outcome. Considering the severity of the disease and the lack of active treatments, 14 pati
Externí odkaz:
https://doaj.org/article/c0fee749597d490eb62cc6d4417d8d39
Autor:
Michele Caraglia, Pierpaolo Correale, Rocco Giannicola, Nicoletta Staropoli, Cirino Botta, Pierpaolo Pastina, Antonello Nesci, Nadia Caporlingua, Edoardo Francini, Laura Ridolfi, Enrico Mini, Giandomenico Roviello, Domenico Ciliberto, Rita Maria Agostino, Alessandra Strangio, Domenico Azzarello, Valerio Nardone, Antonella Falzea, Salvatore Cappabianca, Marco Bocchetti, Graziella D'Arrigo, Giovanni Tripepi, Pierfrancesco Tassone, Raffaele Addeo, Antonio Giordano, Luigi Pirtoli, Guido Francini, Pierosandro Tagliaferri
Publikováno v:
Frontiers in Oncology, Vol 9 (2019)
Background: GOLFIG is a chemo-immunotherapy regimen established in preclinical models that combines gemcitabine + FOLFOX (fluoropyrimidine backbone coupled to oxaliplatin) poly-chemotherapy with low-dose s. c. recombinant interleukin-2 (rIL-2) and gr
Externí odkaz:
https://doaj.org/article/7170bd6fde8f4eec8eb14aa1cf9dfeb1
Autor:
Valerio Nardone, Rocco Giannicola, Diana Giannarelli, Rita Emilena Saladino, Domenico Azzarello, Caterina Romeo, Giovanna Bianco, Maria Rosaria Rizzo, Irene Di Meo, Antonio Nesci, Pierpaolo Pastina, Antonia Consuelo Falzea, Daniele Caracciolo, Alfonso Reginelli, Michele Caraglia, Amalia Luce, Luciano Mutti, Antonio Giordano, Salvatore Cappabianca, Luigi Pirtoli, Vito Barbieri, Pierfrancesco Tassone, Pierosandro Tagliaferri, Pierpaolo Correale
Publikováno v:
Life, Vol 11, Iss 11, p 1235 (2021)
An immune checkpoint blockade with mAbs to PD-1 and PD-L1 is an expanding therapeutic option for mNSCLC patients. This treatment strategy is based on the use of mAbs able to restore the anti-tumor activity of intratumoral T cells inhibited by PD-1 bi
Externí odkaz:
https://doaj.org/article/62314baa55cc425bb501c2b7b1efcaef
Autor:
Ludovico La Grutta, Erica Maffei, Alberto Clemente, Giambattista Privitera, Marco Rengo, Sara Seitun, Roberto Malagò, Patrizia Toia, Manlio Acquafresca, Francesco Secchi, Matteo Gravina, Cesare Mantini, Arnaldo Scardapane, Roberto De Rosa, Luca Maria Carusi, Stefano Cossa, Fabio Falzea, Dante Chiappino, Andrea Annoni, Marco Francone, Ernesto Di Cesare, Massimo Midiri, Filippo Cademartiri
Publikováno v:
Journal of Thoracic Imaging. 38:128-135
Purpose: The Italian Registry of Contrast Material use in Cardiac Computed Tomography (iRCM-CCT) is a multicenter, multivendor, observational study on the use of contrast media (CM) in patients undergoing cardiac computed tomography (CCT). The aim of